3D系统(DDD)
搜索文档
3D Systems (DDD) Boosts Digital Dentistry With New Technology
ZACKS· 2024-06-06 00:00
3D Systems (DDD) is expanding its footprint in the digital dentistry market with its recent announcement of a comprehensive technology roadmap aimed at delivering a diverse range of solutions.The roadmap will include solutions aimed at enhancing the alignment, protection, repair and replacement of teeth, making 3D Systems a frontrunner among additive manufacturing solutions providers. The expansion comes alongside a significant multi-year purchase agreement projected to exceed a quarter-billion dollars in v ...
3D Systems Provides Important Update on Dental Growth Strategy
GlobeNewswire News Room· 2024-06-05 04:15
Company rapidly expanding market-leading solution portfolio to address all major facets of dentistry, including alignment, protection, repair, and partial/full replacement of teethAnnounces largest contract award in company history, with estimated value approaching a quarter billion dollars over five years, to support indirect manufacturing process for clear alignersCommercial launch of direct printing technology for clear aligners targeted for late 2025Dual-material printing technologies enabling expansion ...
3D Systems Provides Important Update on Dental Growth Strategy
Newsfilter· 2024-06-05 04:15
3D Systems Corp Faces A 2030 Feast-Or-Famine Scenario
Seeking Alpha· 2024-05-31 19:42
公司概述 - 3D Systems Corporation 是一家垂直整合的3D打印公司,涉及3D打印机的开发、生产、维护和材料供应。公司通过并购策略在过去20年巩固了其在3D打印行业的地位。预计全球3D打印行业从2020年代初到2030年将以约20%的复合年增长率增长,到2030年达到约1000亿美元的市场价值[1] 生物打印机会 - 3D Systems 在生物打印领域,特别是3D器官打印方面具有重要机会。公司是少数能够大规模打印人体器官的领先企业之一,这可能显著改善全球许多人的生活质量[2][3] 财务状况 - 截至撰写时,3D Systems 的市值约为4.7亿美元,拥有约3.3亿美元的现金和3.8亿美元的债务。公司的运营现金流在过去几年中大部分为正,但净收入多数年份为负,2023财年净亏损超过3.7亿美元[6] - 公司近年来的运营现金流为负,显示核心业务面临挑战。收入多年来持平并开始下降,削弱了公司的盈利基础[7][8] 成本削减与投资 - 面对收入下降和需求疲软,3D Systems 计划削减成本以减少亏损,同时保留对新产品开发的关键投资,以支持未来的增长[9] 债务情况 - 2021年,3D Systems 发行了4.6亿美元的零息可转换债券,将于2026年11月到期。公司在2023年第四季度偿还了约30%的债务,但仍有超过3亿美元的债务需要管理[10] 器官打印市场机会 - 在美国,器官移植网络存在严重的供需不平衡,每天有超过12名美国人因等待器官而死亡。欧洲也面临类似问题。器官打印技术的发展和商业化预计将在2020年代末或2030年代初实现[12][13] - 器官打印市场预计将以近20%的复合年增长率增长,到2030年达到约70亿美元。3D Systems 预计将占据至少20%的市场份额,特别是在北美、欧洲和亚太地区[29][30] 竞争分析 - 3D Systems 在器官打印领域的直接竞争对手包括Organovo Holdings、BICO Group AB、Tissue Regenix Group plc 和 Biolife4D Corporation,但这些公司的市场资本化远小于3D Systems,且资源有限[25][26][27] 2030年股价预测 - 基于对3D Systems 在2030年的收入预测和市场机会,预计公司股票在2030年的价格可能达到每股54.62美元,较当前价格有显著增长[41][42] 风险因素 - 3D Systems 面临财务压力,包括高现金消耗和债务问题,可能导致公司在短期内财务紧张。此外,器官打印技术的商业化可能受到法律、伦理和监管障碍的影响[47][48]
New Strong Sell Stocks for April 25th
Zacks Investment Research· 2024-04-25 19:46
3D Systems Corporation (DDD) - 3D Systems Corporation (DDD) 提供3D打印和数字制造解决方案,当前年度盈利预期在过去60天内下调了225%[1] Eagle Bancorp, Inc. (EGBN) - Eagle Bancorp, Inc. (EGBN) 是EagleBank的银行控股公司,当前年度盈利预期在过去60天内下调了8.7%[2] FinWise Bancorp (FINW) - FinWise Bancorp (FINW) 是FinWise Bank的银行控股公司,当前年度盈利预期在过去60天内下调了7.5%[3]
3D Systems' (DDD) Cranial Implant Solution Receives FDA Nod
Zacks Investment Research· 2024-04-16 23:51
3D Systems (DDD) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its innovative 3D-printed, patient-specific cranial implant solution, the VSP PEEK Cranial Implant.VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP i4 3DF PEEK (polyetheretherketone), and a pre-defined production process.The VSP PEEK Cranial Implant integrates cutting-ed ...
3D Systems Announces FDA Clearance for World's First 3D-Printed PEEK Cranial Implants
Newsfilter· 2024-04-15 20:30
FDA clearance enables wide-spread adoption of 3D Systems self-contained, cleanroom environment-based printing system, the EXT 220 MED, with medical-grade PEEK materials to deliver patient-specific cranial reconstruction solutions3D-printed PEEK implants using the EXT 220 MED successfully demonstrated in nearly 40 cranioplasties across Europe in recent monthsMarket for cranial reconstruction anticipated to exceed $2 billion by 2030FDA clearance establishes strong foundation for expanded application of these ...
3D Systems' (DDD) Metal 3D Printers Gain Adoption at Wilting
Zacks Investment Research· 2024-03-14 00:26
公司整合 - Wilting公司整合了3D Systems的DMP Flex 350平台,以提高生产能力和材料组合,满足客户需求[1][3] 未来增长预期 - 3D Systems积极追求可扩展性,预计未来五到七年增长率将超过20%,达到800亿美元[9][10] 新产品发布计划 - 3D Systems在2023年第四季度推出了多款新产品和材料,预计到2024年底将推出40款新产品[11]
Wilting Expands Production Capacity with Three DMP Flex 350 Printers
Newsfilter· 2024-03-12 20:30
Wilting公司新设备投入 - Wilting公司新增了两台单激光和一台双激光DMP Flex 350金属3D打印机,以扩展材料组合,满足新应用需求[1] - DMP Flex 350平台设计灵活,可用于应用开发到批量生产,快速更换建模模块和粉末回收加速生产[2] Wilting公司合作与扩张 - Wilting公司通过与3D Systems的合作,加速了金属增材制造能力和专业知识的采用,现在正计划扩大到新市场和应用领域[3]
3D Systems Announces Additional Partial Repurchase of Convertible Senior Notes
Newsfilter· 2024-03-05 21:00
公司回购 - 公司宣布以22%的折扣回购了价值约1.1亿美元的0%票面利率可转换高级票据[1] - 该回购将剩余未偿还票据余额降至约2.14亿美元,比最初发行的4.6亿美元本金余额减少了超过50%,到期日为2026年[1] 公司管理负债 - 公司总裁兼首席执行官杰弗里·格雷夫斯表示,此次回购再次展示了公司在主动管理负债和在当前环境中执行纪律的方法,强调了公司资产负债表实力的重要性[3]